Documents
Application Sponsors
| ANDA 075416 | ACTAVIS LABS FL INC | |
Marketing Status
| Prescription | 001 |
| Prescription | 002 |
| Prescription | 003 |
Application Products
| 001 | TABLET, EXTENDED RELEASE;ORAL | EQ 500MG BASE | 0 | NAPROXEN SODIUM | NAPROXEN SODIUM |
| 002 | TABLET, EXTENDED RELEASE;ORAL | EQ 375MG BASE | 0 | NAPROXEN SODIUM | NAPROXEN SODIUM |
| 003 | TABLET, EXTENDED RELEASE;ORAL | EQ 750MG BASE | 0 | NAPROXEN SODIUM | NAPROXEN SODIUM |
FDA Submissions
| ORIG | 1 | AP | 2002-08-27 | |
| LABELING; Labeling | SUPPL | 2 | AP | 2003-04-23 | |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 2003-04-23 | |
| LABELING; Labeling | SUPPL | 6 | AP | 2007-04-03 | |
| LABELING; Labeling | SUPPL | 8 | AP | 2008-02-21 | |
| LABELING; Labeling | SUPPL | 12 | AP | 2015-04-15 | STANDARD |
| LABELING; Labeling | SUPPL | 16 | AP | 2016-09-08 | STANDARD |
| LABELING; Labeling | SUPPL | 19 | AP | 2019-11-25 | STANDARD |
Submissions Property Types
| SUPPL | 1 | Null | 0 |
| SUPPL | 3 | Null | 0 |
| SUPPL | 12 | Null | 7 |
| SUPPL | 16 | Null | 31 |
| SUPPL | 19 | Null | 7 |
TE Codes
| 001 | Prescription | AB |
| 002 | Prescription | AB |
| 003 | Prescription | AB |
CDER Filings
ACTAVIS LABS FL INC
cder:Array
(
[0] => Array
(
[ApplNo] => 75416
[companyName] => ACTAVIS LABS FL INC
[docInserts] => ["",""]
[products] => [{"drugName":"NAPROXEN SODIUM","activeIngredients":"NAPROXEN SODIUM","strength":"EQ 500MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"NAPROXEN SODIUM","activeIngredients":"NAPROXEN SODIUM","strength":"EQ 375MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"NAPROXEN SODIUM","activeIngredients":"NAPROXEN SODIUM","strength":"EQ 750MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"NAPROXEN SODIUM","submission":"NAPROXEN SODIUM","actionType":"EQ 500MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"NAPROXEN SODIUM","submission":"NAPROXEN SODIUM","actionType":"EQ 375MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"NAPROXEN SODIUM","submission":"NAPROXEN SODIUM","actionType":"EQ 750MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)